These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11964870)

  • 1. Recent advances in vaccines against viral haemorrhagic fevers.
    Baize S; Marianneau P; Georges-Courbot MC; Deubel V
    Curr Opin Infect Dis; 2001 Oct; 14(5):513-8. PubMed ID: 11964870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses.
    Hastie KM; Bale S; Kimberlin CR; Saphire EO
    Curr Opin Virol; 2012 Apr; 2(2):151-6. PubMed ID: 22482712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren.
    Blackburn NK; Searle L; Taylor P
    Trans R Soc Trop Med Hyg; 1982; 76(6):803-5. PubMed ID: 6761909
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemorrhagic fever vaccine.
    Drugs R D; 1999 Sep; 2(3):197-8. PubMed ID: 10641225
    [No Abstract]   [Full Text] [Related]  

  • 5. [The vaccines based on the replicon of the venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers].
    Petrov AA; Plekhanova TM; Sidorova ON; Borisevich SV; Makhlay AA
    Vopr Virusol; 2015; 60(3):14-8. PubMed ID: 26281301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for viral hemorrhagic fevers--progress and shortcomings.
    Falzarano D; Feldmann H
    Curr Opin Virol; 2013 Jun; 3(3):343-51. PubMed ID: 23773330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Pathogen Innovative (5 in 1) Vaccine for Viral Haemorrhagic Fevers will Save More Lives.
    Ohanu M; Ezenwugo UC; Nwafia I; Ebede S
    West Afr J Med; 2023 Jan; 40(1):121-124. PubMed ID: 36718761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
    Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
    Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.
    Zivcec M; Spiropoulou CF; Spengler JR
    Antiviral Res; 2020 Feb; 174():104702. PubMed ID: 31982149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in the development of vaccines against hemorrhagic fevers caused by arenaviruses].
    Mateo M; Baize S
    Med Sci (Paris); 2023 Nov; 39(11):855-861. PubMed ID: 38018929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment].
    Borisevich IV; Markin VA; Firsova IV; Evseev AA; Khamitov RA; Maksimov VA
    Vopr Virusol; 2006; 51(5):8-16. PubMed ID: 17087059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B; Duquesnoy P; Languillat G; Saluzzo JF; Georges A; Gonzalez JP; McCormick J
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral hemorrhagic fever].
    Kager PA
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):448-51. PubMed ID: 9562757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-epidemiologic and laboratory research on hemorrhagic fevers in Guinea].
    Boiro I; Lomonossov NN; Sotsinski VA; Constantinov OK; Tkachenko EA; Inapogui AP; Balde C
    Bull Soc Pathol Exot Filiales; 1987; 80(4):607-12. PubMed ID: 3440310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
    Kunz S
    Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against viral hemorrhagic fevers: non-human primate models.
    Carrion R; Patterson JL
    Hum Vaccin; 2011 Jun; 7(6):667-73. PubMed ID: 21445006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
    Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
    Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.